在慢性阻塞性肺病患者中,乙酸细胞数量和预后之间的关联
Wan-Hsuan Hsu1, Bo-Wen Shiau1, Chih-Cheng Lai2,3
1Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
Frontiers in medicine
|September 19, 2025
概括
慢性阻塞性肺部疾病 (COPD) 患者的血中乙氨基酸细胞数量较高与恶化,呼吸衰竭和死亡率的风险增加有关. 降低乙氨基细胞可能会改善COPD的结果.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 免疫学 免疫学 免疫学
背景情况:
- 在慢性阻塞性肺部疾病 (COPD) 中,血中乙氨基基基水平的预后意义受到争议.
- 乙氨基酸可以预测COPD患者的恶化和临床结果.
- 澄清乙素-COPD关系对于患者管理至关重要.
研究的目的:
- 调查血中乙氨基酸细胞数量与急性恶化,急性呼吸衰竭 (ARF) 和COPD患者死亡率的风险之间的关联.
- 为了比较乙性 (≥300细胞/μL) 和非乙性 (<300细胞/μL) COPD 患者组之间的结果.
主要方法:
- 使用TrinetX全球多中心研究数据库进行回顾性队列研究.
- 在3年的随访期间,对40岁以上被诊断患有COPD的患者进行分析.
- 使用了倾向性得分匹配,考克斯比例危险模型和卡普兰-梅尔分析.
主要成果:
- 非乙酸性组 (<300细胞/μL) 的风险明显低于乙酸性组 (≥300细胞/μL) 的风险.
- 降低了COPD恶化的风险 (HR 0.790),所有原因死亡率 (HR 0.818) 和ARF (HR 0.721) 在非eosinophilic组中观察到.
- 所有的比较都显示出统计学意义 (p < 0.001).
结论:
- 血中乙氨基酸细胞数量的增加与COPD恶化,ARF和死亡率的风险增加有关.
- 血中乙氨基酸水平可以作为COPD不良结果的预测生物标志物.
- 进一步的研究可以探索用于COPD管理的向性乙氨基小细胞减少策略.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
737
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
737
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K